June - 2019

top of page

Sage Group News

Opportunity for Leadership in Epigenetic Control of Metastatic Cancer

Sage is representing EpiAxis Therapeutics. We are seeking strategic partners to license their novel technology for epigenetic control of...

OraMelts Drug Delivery Platform: Opportunity for Leadership in IntraOral Drug Delivery

The Sage Group is representing Quest Consumer Health Holdings, the owner of the OraMelts manufacturing facility and patent portfolio, in...

bottom of page